Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07361445 · ClinicalTrials.gov registry record · NA
Agilis RF TSP Early Feasibility Study
A NA study of Left Atrial Appendage Closure and Cardiac Arrythmias, sponsored by Abbott Medical Devices.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 2
- Study locations
NCT07361445 is a NA study of Left Atrial Appendage Closure and Cardiac Arrythmias that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 20 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT07361445, a NA study of Left Atrial Appendage Closure and Cardiac Arrythmias, is actively recruiting participants, sponsored by Abbott Medical Devices.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is a prospective, acute, first-in-human, early feasibility study intended to assess the initial safety and performance of the Agilis™ Radiofrequency (RF) Transseptal (TSP) System in crossing the atrial septum for left atrial and left ventricular access during cardiac electrophysiology (EP) and interventional cardiology (IC) procedures. This study will be conducted in an acute setting. Subjects will be followed through hospital discharge, and no follow-up visits will be required for this study.
Conditions Studied
Interventions
- DEVICE Transseptal procedure with Agilis RF TSP System.
Study Locations (2)
Arkansas
- Arrhythmia Research Group (St. Bernards) - Jonesboro
California
- California Pacific Medical Center -Van Ness Campus - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-02-16 |
| Est. Completion | 2026-08-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07361445
The ClinicalTrials.gov registry entry for NCT07361445 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Left Atrial Appendage Closure appearing as the primary indexed condition, and to 1 intervention - of which Transseptal procedure with Agilis RF TSP System. is the first listed.
NCT07361445 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arkansas, California.
Frequently Asked Questions
What is clinical trial NCT07361445 about?
NCT07361445 is a clinical study titled "Agilis RF TSP Early Feasibility Study". This study is a prospective, acute, first-in-human, early feasibility study intended to assess the initial safety and performance of the Agilis™ Radiofrequency (RF) Transseptal (TSP) System in crossing the atrial septum for left atrial and left ventricular access during cardiac electrophysiology (EP...
What is the current status of trial NCT07361445?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-02-16. Estimated completion is 2026-08-03.
What conditions does trial NCT07361445 study?
This clinical trial studies the following conditions: Left Atrial Appendage Closure, Cardiac Arrythmias.
What interventions are being tested in trial NCT07361445?
The interventions under investigation include: Transseptal procedure with Agilis RF TSP System. (DEVICE).
Who is sponsoring clinical trial NCT07361445?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07361445 being conducted?
This trial has 2 study locations across Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Left Atrial Appendage Closure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.